DETECTOGEN, INC.
Biotech · Private
Non-invasive urine-based diagnostic assay using leishmanial protein biomarkers to diagnose active visceral leishmaniasis and monitor treatment efficacy
- Grants
- $2.3M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a protein-based antigen detection test for kala-azar | $210,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a protein-based antigen detection test for kala-azar | $210,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel non-invasive antigen detection assay for the diagnosis of active visceral leishmaniasis and to monitor the therapy efficacy of this disease | $611,946 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel non-invasive antigen detection assay for the diagnosis of active visceral leishmaniasis and to monitor the therapy efficacy of this disease | $665,346 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel non-invasive antigen detection assay for the diagnosis of active visceral leishmaniasis and to monitor the therapy efficacy of this disease | $651,346 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3078 | Myeloid Therapeutics | — | — |
| 3079 | Cardior Pharmaceuticals | — | — |
| 3080 | DELAQUA PHARMACEUTICALS INC | — | — |
| 3081 | DETECTOGEN, INC. | — | — |
| 3082 | Altigg Therapeutics, Inc. | — | — |
| 3083 | Ventus Therapeutics | — | — |
| 3084 | EVINCIS BIO, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Leishmaniasis Antigen Detection Assays And Vaccinesapplication
- Leishmaniasis Antigen Detection Assays And Vaccinesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.